Brief Detail: Cleaning Validation Master Plan
A Cleaning Validation Master Plan (CVMP) is a main guidance document that explains how cleaning validation will be planned, performed, checked and documented in a pharmaceutical facility.
Its main purpose is to confirm that manufacturing equipment is cleaned properly so that residues from the previous product, cleaning agents and microorganisms do not contaminate the next product.
The plan covers equipment used for products such as tablets, capsules, dry syrups, injections, eye/ear drops, ampoules, ointments, creams, lotions and gels.
Cleaning validation normally includes:
- Selection of the worst-case product, such as the most potent, toxic, poorly soluble or difficult-to-clean product.
- Selection of the worst-case equipment, generally equipment with a larger product-contact surface area or difficult-to-clean parts.
- Calculation of acceptable residue limits.
- Collection of swab and rinse samples from equipment surfaces.
- Testing of product residue, cleaning-agent residue and microbial contamination.
- Visual inspection to confirm that the equipment appears clean.
- Establishment of dirty hold time and clean hold time.
- Preparation of a cleaning-validation protocol and final report.
Quality Assurance coordinates the validation, Quality Control tests the samples, Production performs the cleaning, and Engineering provides equipment details and maintains the required facilities.
Cleaning procedures must consistently meet the approved acceptance limits. Revalidation may be required after major changes in equipment, cleaning agents, cleaning methods or products.
Selection of the Worst-Case Product in Cleaning Validation
A worst-case product is the product that gives the greatest challenge to the equipment-cleaning procedure. It is selected from all products manufactured using the same or similar equipment.
The purpose is to prove that when the cleaning procedure can successfully remove the most difficult product, it should also be capable of removing products that are easier to clean. This is known as the matrix or worst-case approach.
1. Poor solubility in the cleaning solvent
The solubility of the API in the cleaning solvent, normally water, is an important selection criterion.
- A highly soluble API dissolves easily during washing.
- A poorly soluble or insoluble API does not dissolve easily.
- Insoluble material may remain attached to the equipment surface even after rinsing.
Therefore, the product containing the API with the lowest solubility in the cleaning solvent is considered more difficult to clean.
Example:
If Product A is freely soluble in water and Product B is practically insoluble in water, Product B presents the greater cleaning challenge.
2. High potency
A potent product produces its therapeutic effect at a very small dose. Even a small quantity of residue from such a product may be important.
The CVMP considers a low-dose product to be a potentially potent product. Because its acceptable carryover may be very low, the cleaning procedure must remove the residue to a more stringent level.
Example:
A product with a daily dose of 0.5 mg may present a greater concern than a product with a daily dose of 500 mg, depending on its toxicity and calculated acceptance limit.
3. High toxicity
A toxic API may cause harmful effects even when carried over in a small quantity to the next product.
Therefore, the toxicity of each API should be reviewed. A product with greater toxicity may be selected as the worst case because its acceptable residue level may be lower and more difficult to meet.
The selection should not be based only on cleaning difficulty. It should also consider the possible effect of the residue on the safety and quality of the next product.
4. Difficult-to-clean formulation
Some products are physically more difficult to remove from equipment surfaces because they may be:
- Sticky or oily
- Highly coloured
- Viscous
- Strongly adhesive
- Poorly wettable
- Likely to dry and form a hard layer
- Trapped in joints, corners, screens or other difficult locations
Among products having similarly low solubility, the product that is practically more difficult to remove should be given greater importance.
Cleaning history and operator experience may help identify such products.
5. Higher strength or concentration
When the same product is manufactured in different strengths, the higher-strength product should normally be considered.
A higher-strength product may leave a greater concentration of API on the equipment surface. This creates a greater challenge for the cleaning procedure.
The attached CVMP states that where two or more products appear to be worst cases, the product having the higher drug concentration should be selected. It also states that cleaning validation should be conducted after manufacturing the higher-strength product.
6. Batch size
Batch size is also considered during worst-case selection.
A larger batch may expose the equipment to a greater total quantity of product and may produce more residue. The CVMP therefore considers the most potent, toxic and insoluble product together with a high batch size.
However, batch size should be evaluated with other factors rather than used alone.
7. Acceptance limit
The calculated residue acceptance limit should also be considered.
A product with a lower or more stringent acceptance limit can be a stronger worst-case candidate because the equipment must be cleaned to a lower residue level.
For example:
- Product A acceptance limit: 10 µg per swab
- Product B acceptance limit: 1 µg per swab
Product B may be the more critical product because its permitted residue is much lower, provided the analytical method can reliably detect and quantify that level.
8. Products containing more than one API
Where a formulation contains more than one active ingredient, the CVMP recommends evaluating the API that is:
- More insoluble in water
- More potent
- More toxic
- More difficult to remove
The most critical API becomes the target residue for cleaning validation testing.
Information included in the product matrix
A product matrix should be prepared to compare all products manufactured on the same equipment train. The attached CVMP lists the following details:
| Parameter | Purpose |
|---|---|
| Product name | Identifies the product |
| Active ingredient | Identifies the residue to be evaluated |
| Batch size | Shows the quantity manufactured |
| Dose weight | Helps assess product strength and exposure |
| Solubility in cleaning solvent | Indicates how easily the API can be removed |
| Smallest recommended daily dose | Helps identify potent or low-dose products |
| Largest recommended daily dose | Supports evaluation of product exposure |
| Potency and toxicity | Identifies products requiring stringent control |
| Cleaning difficulty | Identifies sticky, oily, coloured or adherent products |
| Acceptance limit | Identifies the product with the strictest residue limit |
Practical selection procedure
Step 1: Prepare the product list
List all products manufactured using the same equipment or equipment train.
Step 2: Collect product information
Collect information about each product’s:
- API
- Strength
- Batch size
- Daily dose
- Water solubility
- Potency
- Toxicity
- Cleaning behaviour
- Calculated acceptance limit
Step 3: Compare the products
Identify products that are:
- Least soluble
- Most potent
- Most toxic
- Most difficult to clean
- Manufactured at higher strength
- Associated with stricter acceptance limits
Step 4: Select the leading candidate
Select the product that presents the greatest combined cleaning and patient-safety challenge.
No single parameter should automatically decide the worst case. All relevant parameters should be evaluated together with a documented scientific rationale.
Step 5: Document the justification
The selection report should clearly explain:
- Why the product was selected
- Which API will be tested
- Which products and equipment are covered by the selection
- Why the selected product represents the other products
- Which acceptance limit will be applied
Step 6: Perform cleaning validation
Manufacture the selected worst-case product, clean the equipment according to the approved SOP, and collect samples from the identified locations.
Swab sampling is generally used for accessible and difficult-to-clean surfaces, while rinse sampling may be used for locations that cannot be reached directly.
Simple illustrative example
| Product | Solubility | Daily dose | Toxicity | Cleaning difficulty | Likely assessment |
|---|---|---|---|---|---|
| Product A | Freely soluble | 500 mg | Low | Easy | Low challenge |
| Product B | Slightly soluble | 50 mg | Moderate | Moderate | Medium challenge |
| Product C | Practically insoluble | 1 mg | High | Sticky and coloured | Highest challenge |
In this example, Product C would normally be selected because it is poorly soluble, potent, toxic and difficult to clean. This table is only an illustration; the attached CVMP does not prescribe a fixed numerical scoring system.
